China National Medicines Corporation Ltd. (SHA:600511)
China flag China · Delayed Price · Currency is CNY
27.34
-0.28 (-1.01%)
Oct 22, 2026, 3:00 PM CST

SHA:600511 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
1,9811,9972,0002,1461,9641,754
Depreciation & Amortization
229.04229.04240.54199.75189.61178.83
Other Amortization
19.2519.259.538.577.84-
Loss (Gain) From Sale of Assets
-0.21-0.210.19-0.08-1.68-
Asset Writedown & Restructuring Costs
0.10.100.055.23-
Loss (Gain) From Sale of Investments
-585.38-585.38-532.08-369.77-291.62-
Provision & Write-off of Bad Debts
34.134.122.829.1723.8-
Other Operating Activities
-214.81125.54164.38228.17203.3724.54
Change in Accounts Receivable
-692.57-692.57-442.42-292.55599.77-
Change in Inventory
-240.87-240.87-993.86-243.6-207.59-
Change in Accounts Payable
1,1401,1401,2181,048-87.62-
Operating Cash Flow
1,6492,0061,6592,7272,3951,957
Operating Cash Flow Growth
158.27%20.88%-39.15%13.84%22.36%50.38%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-69.26-68.19-130.77-145.12-129.78-95.07
Sale of Property, Plant & Equipment
0.150.20.390.163.520.78
Cash Acquisitions
-----15.2-15.82
Investment in Securities
18.2818.33-2,4777.88-12.6-15.75
Other Investing Activities
-315.1232.2723.757.771.742.86
Investing Cash Flow
-327.51-17.39-2,584-129.31-152.32-122.99

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-319.45315.98203.2335.61793.18
Total Debt Issued
216319.45315.98203.2335.61793.18
Short-Term Debt Repaid
--923.45-1,033-250-509.86-864.55
Long-Term Debt Repaid
--117.09-117.81-81.71-117.07-72.35
Lease Payments
-117.09-117.09-117.81-81.71-107.07-61.25
Total Debt Repaid
-676.1-1,041-1,151-331.71-626.93-936.91
Net Debt Issued (Repaid)
-460.1-721.09-835.11-128.51-291.32-143.72
Common Dividends Paid
-620.41-625.74-682.43-709.58-611.96-637.77
Other Financing Activities
-177.3-40.65-64.8205.91263.7135.53
Financing Cash Flow
-1,258-1,387-1,582-632.18-639.57-745.96

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
63.8600.65-2,5071,9651,6031,088

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
1,5801,9371,5282,5822,2651,862
Free Cash Flow Growth
178.20%26.76%-40.80%13.96%21.64%51.09%
Free Cash Flow Margin
2.94%3.69%3.02%5.20%4.98%4.01%
Free Cash Flow Per Share
2.092.572.033.423.002.47
Levered Free Cash Flow
972.171,19814.862,1852,0731,497
Unlevered Free Cash Flow
985.921,21535.892,2052,0891,524
Free Cash Flow After Leases
1,4631,8201,4112,5002,1581,801

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
1,7491,7711,4791,4501,3501,300
Change in Working Capital
186.49186.49-246.38504.79294.52-